Tatva Chintan Pharma Chem consolidated net profit rises 27.64% in the June 2025 quarter
Net profit of Tatva Chintan Pharma Chem rose 27.64% to Rs 6.65 crore in the quarter ended June 2025 as against Rs 5.21 crore during the previous quarter ended June 2024. Sales rose 10.81% to Rs 116.86 crore in the quarter ended June 2025 as against Rs 105.46 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 116.86 | 105.46 | 11 |
| OPM % | 14.83 | 11.97 | - |
| PBDT | 18.07 | 13.47 | 34 |
| PBT | 9.10 | 6.81 | 34 |
| NP | 6.65 | 5.21 | 28 |